Finally, we tested our clock on a second validation cohort and a group of cognitively normal but amyloid beta plaque positive (Aβ+) individuals to see if this presymptomatic AD group demonstrated accelerated biological aging in the CNS. This evidence concerns the gene CLOCK and Alzheimer disease.